Literature DB >> 23414881

Intestinal perforation after treatment of Burkitt's lymphoma: case report and review of the literature.

Sara C Fallon1, Michele S Redell, Javier El-Bietar, Monica E Lopez, Sanjeev A Vasudevan, Mary L Brandt.   

Abstract

Non-Hodgkin's Lymphoma (NHL) is the most common intestinal malignancy in children, and Burkitt's lymphoma is the most frequently encountered histologic subtype. In pediatric patients, intestinal involvement of the lymphoma is a common finding. As over half of these intestinal tumors are unresectable at the time of presentation, chemotherapy is the mainstay of treatment. However, as the tumor responds to chemotherapy, regression of the tumor in the bowel wall can result in intestinal perforation. We report a unique case of a pediatric patient with lymphoma-related intestinal perforation which was managed with a damage control laparotomy, discuss operative management strategies in these difficult cases, and provide a review of similar cases in the literature.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23414881     DOI: 10.1016/j.jpedsurg.2012.12.002

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

1.  Bowel perforation associated with robust response to BRAF/MEK inhibitor therapy for BRAF-mutant melanoma: a case report.

Authors:  Samantha L Kass; Allison F Linden; Patrick G Jackson; Pedro A De Brito; Michael B Atkins
Journal:  Melanoma Manag       Date:  2015-05-18

2.  Burkitt lymphoma involving jejunum in children.

Authors:  Zhi Li; Jiexiong Feng; Xiaoyi Sun
Journal:  Ann Med Surg (Lond)       Date:  2014-06-26

Review 3.  Emergency imaging in paediatric oncology: a pictorial review.

Authors:  Trevor Gaunt; Felice D'Arco; Anne M Smets; Kieran McHugh; Susan C Shelmerdine
Journal:  Insights Imaging       Date:  2019-12-18

4.  Intestinal atresia following chemotherapy, presenting as superior mesenteric artery syndrome: A case report.

Authors:  Xing Wang; Jian-Zhong Li; Ying-Hui Yang; Xiao-Li Huang; Yu Wang; Bin Wu
Journal:  Mol Clin Oncol       Date:  2017-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.